The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction
Open accessAbstract
BACKGROUND: Immunoassays are widely used in clinical laboratories for measurement of plasma/serum concentrations of steroid hormones such as cortisol and testosterone. Immunoassays can be performed on a variety of standard clinical chemistry analyzers, thus allowing even small clinical laboratories to do analysis on-site. One limitation of steroid hormone immunoassays is interference caused by compounds with structural similarity to the target steroid of the assay. Interfering molecules include structurally related endogenous compounds and their metabolites as well as drugs such as anabolic steroids and synthetic glucocorticoids. METHODS: Cross-reactivity of a structurally diverse set of compounds were determined for the Roche Diagnostics Elecsys assays for cortisol, dehydroepiandrosterone (DHEA) sulfate, estradiol, progesterone, and testosterone. These data were compared and contrasted to package insert data and published cross-reactivity studies for other marketed steroid hormone immunoassays. Cross-reactivity was computationally predicted using the technique of two-dimensional molecular similarity. RESULTS: The Roche Elecsys Cortisol and Testosterone II assays showed a wider range of cross-reactivity than the DHEA sulfate, Estradiol II, and Progesterone II assays. 6-Methylprednisolone and prednisolone showed high cross-reactivity for the cortisol assay, with high likelihood of clinically significant effect for patients administered these drugs. In addition, 21-deoxycortisol likely produces clinically relevant cross-reactivity for cortisol in patients with 21-hydroxylase deficiency, while 11-deoxycortisol may produce clinically relevant cross-reactivity in 11β-hydroxylase deficiency or following metyrapone challenge. Several anabolic steroids may produce clinically significant false positives on the testosterone assay, although interpretation is limited by sparse pharmacokinetic data for some of these drugs. Norethindrone therapy may impact immunoassay measurement of testosterone in women. Using two-dimensional similarity calculations, all compounds with high cross-reactivity also showed a high degree of similarity to the target molecule of the immunoassay. CONCLUSIONS: Compounds producing cross-reactivity in steroid hormone immunoassays generally have a high degree of structural similarity to the target hormone. Clinically significant interactions can occur with structurally similar drugs (e.g., prednisolone and cortisol immunoassays; methyltestosterone and testosterone immunoassays) or with endogenous compounds such as 21-deoxycortisol that can accumulate to very high concentrations in certain disease conditions. Simple similarity calculations can help triage compounds for future testing of assay cross-reactivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Serum T3 or free T3 (fT3) levels are generally not helpful in diagnosing CH; most patients with CH have low fT3 levels, but there is considerable overlap between CH and non-CH patients with pituitary MAY 4, 2016 disease (75,77).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [75]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Many patients with CH have undetectable TSH levels on presentation, and almost all CH patients adequately treated with L-T4 to maintain serum fT4 levels in the mid-to high-normal range will have undetectable TSH levels (75,80,127,129).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
Burtis, E. B. C. A., Ashwood, E. R., & Bruns, D. E. (2011) · Medical Entomology and Zoology · Cited by 2,190
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614 · cited 1×
“Comparison of similarity of test molecules to the target compounds of the steroid immunoassays used twodimensional (2D) similarity analysis, which determines the similarity between molecules independent of any in vitro data [52-54].”
In silico pharmacology for drug discovery: applications to targets and beyond
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707306 · Cited by 365 · cited 2×
“Comparison of similarity of test molecules to the target compounds of the steroid immunoassays used twodimensional (2D) similarity analysis, which determines the similarity between molecules independent of any in vitro data [52-54].”
Self-citationVirtual Screening in Drug Discovery - A Computational Perspective
Reddy, A. S., Pati, S. P., Kumar, P. P., Pradeep, H. N., & Sastry, G. N. (2007) · Current Protein & Peptide Science · doi:10.2174/138920307781369427 · Cited by 350 · cited 1×
“Comparison of similarity of test molecules to the target compounds of the steroid immunoassays used twodimensional (2D) similarity analysis, which determines the similarity between molecules independent of any in vitro data [52-54].”
Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels
Ho, J. T., Al-Musalhi, H., Chapman, M. J., Quach, T., Thomas, P. D., Bagley, C. J., Lewis, J. G., & Torpy, D. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0265 · Cited by 312 · cited 4×
“These methods have been applied in our previous publications on cross-reactivity of drug of abuse and therapeutic drug monitoring immunoassays [14-17].”
InfluentialAdvantages and challenges of mass spectrometry assays for steroid hormones
Stanczyk, F. Z., & Clarke, N. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.001 · Cited by 265 · cited 1×
“However, a growing number of studies have documented differences between immunoassays and mass spectrometry methods (especially LC/ MS/MS) [6,7,58-63].”
Steroid Hormone Analysis by Tandem Mass Spectrometry
Soldin, S. J., & Soldin, O. P. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2007.100008 · Cited by 264 · cited 3×
“Cross-reactivity to endogenous or exogenous compounds other than the target steroid hormone of the assay may also contribute to differences between immunoassay and LC/MS/MS [4,7,34,60,61].”
Shackleton, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.017 · Cited by 226 · cited 2×
“However, a growing number of studies have documented differences between immunoassays and mass spectrometry methods (especially LC/ MS/MS) [6,7,58-63].”
Huhtaniemi, I. T., Tajar, A., Lee, D. M., O'Neill, T. W., Finn, J. D., Bartfai, G., Boonen, S., Casanueva, F. F., Giwercman, A., Han, T. S., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1051 · Cited by 201 · cited 2×
“Estradiol immunoassays often do not perform well relative to LC/MS/MS in measuring the lower end of estradiol concentrations found in males, a limitation likely related primarily to differing lower limits of quantitation between the methods [59,62,64,65].”
Evans, T. R. J., di Salle, E., Ornati, G., Lassus, M., Benedetti, M. S., Pianezzola, E., & Coombes, R. C. (1992) · PubMed · Cited by 161
Research works printed but not linked: 1
- Powers DM, Boyd JC, Glick MR: Interference testing in clinical chemistry (EP7-A). 1986, NCCLS: Villanova, PA
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Measuring cortisol in serum, urine and saliva—Are our assays good enough?
El-Farhan, N., Rees, D. A., & Evans, C. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216687335 · Cited by 395
Yeasmin, S., Wu, B., Liu, Y., Ullah, A., & Cheng, L.-J. “. (2022) · SSRN Electronic Journal · doi:10.1016/j.bios.2022.114142 · Cited by 161
High-Affinity Nucleic-Acid-Based Receptors for Steroids
Yang, K.-A., Chun, H.-S., Zhang, Y., Pecic, S., Nakatsuka, N., Andrews, A. M., Worgall, T. S., & Stojanović, M. N. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00634 · Cited by 134
Metadata
- Authors
- Krasowski, M. D., Drees, D., Morris, C. S., Maakestad, J., Blau, J. L., & Ekins, S.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Michigan (US)
- Corresponding author
- Krasowski, Matthew D
- Venue
- BMC Clinical Pathology
- Published
- 2014-07-14
- Volume
- 14
- Issue
- 1
- Pages
- 33-33
- ISSN
- 1472-6890 (ISSN-L)
- PMC
- PMC4112981
- OpenAlex
- W2043223954
- Semantic Scholar
- a9545d47c49699a6c80a80bc0eb4df29b3fff7b7
- Cited by
- 212
- References
- 65
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 25 · 2023: 17 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 18 · 2018: 11 · 2017: 18 · 2016: 15 · 2015: 5 · 2014: 1
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BMC Clinical Pathology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- cross-reactivity, immunoassay interference, cortisol, testosterone, dehydroepiandrosterone sulfate, estradiol, progesterone, 21-deoxycortisol, 11-deoxycortisol, 21-hydroxylase deficiency, 11beta-hydroxylase deficiency, anabolic steroids, synthetic glucocorticoids, norethisterone, false positives, structural similarity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. https://app.cochat.ai/papers/10.1186/1472-6890-14-33
- The paper
- Krasowski, M. D., Drees, D., Morris, C. S., Maakestad, J., Blau, J. L., & Ekins, S. (2014). Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clinical Pathology. https://doi.org/10.1186/1472-6890-14-33
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.